Status:
NOT_YET_RECRUITING
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Collaborating Sponsors:
521 Hospital of NORINCO Group
Shaanxi Provincial People's Hospital
Conditions:
Ventricular Arrythmia
Eligibility:
All Genders
18-80 years
Brief Summary
The investigation of biomarkers for immune status and metabolic state, as well as host microbiota composition, in patients with ventricular arrhythmias before and after radiofrequency ablation, can pr...
Detailed Description
Abnormal immune and metabolic states can lead to the occurrence of various systemic diseases, including the development of cardiovascular diseases through multiple mechanisms. On the other hand, vario...
Eligibility Criteria
Inclusion
- Patients with ventricular premature beats, ventricular tachycardia, or ventricular fibrillation detected by regular surface twelve-lead electrocardiogram or Holter.
Exclusion
- Age \<18 or \>80 years old;
- Patients with autoimmune diseases or immune deficiencies, or those who have used immunosuppressive or immune modulating agents in the past 3 months;
- Platelet count \<100×10\^9/L or functional platelet defects;
- Congenital or acquired coagulation or bleeding disorders;
- Patients with a history of organ transplantation or are preparing to receive organ transplantation;
- Unwilling to sign an informed consent or cooperate with the examination.
Key Trial Info
Start Date :
December 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05965375
Start Date
December 31 2024
End Date
May 31 2027
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Xian Jiantong University
Xi'an, Shaanxi, China, 710061